Close
Xylem
Facebook Linkedin Twitter Youtube
  • Home
  • News
  • Articles
  • Press Releases
  • Events
  • Reports
  • BioPharma
  • Nutraceutical
  • More
    • Contact Us
    • Interviews
    • White Papers
    • Newsletter Archive
    • Target Audience
    • Magazine Issues
    • Testimonials
Search
  • Home
  • Magazine
  • Videos
  • Gallery
  • Newsletters
  • Media Packs
  • Advertise
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
World Pharma Today
Thermofisher
  • Home
  • News
    • Biomarkers, Second Opinion, and Immunotherapy Planning for Stage 4 Colon Cancer With Booking Health

      Biomarkers, Second Opinion, and Immunotherapy Planning for Stage 4 Colon Cancer…

      Purity on Paper Isn’t Enough: How Procurement Teams Are Raising the…

      Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

      Boehringer Ingelheim Integrates Owkin K Pro AI to Accelerate Drug Discovery

      EMA Initiates Data Sharing Pilot for New Approach Methodologies

      EMA Initiates Data Sharing Pilot for New Approach Methodologies

      Infographic announcing a $3.22B Novartis‑Alteogen deal for subcutaneous drug innovation in a high‑tech lab with three explanatory bubbles: agreement value, ALT‑B4 tech, and global grants.

      Novartis Signs $3.22 Billion Deal with Alteogen for Subcutaneous Drug Technology

  • Articles
    • low GWP pMDIs

      Why the fastest route to low-GWP pMDIs requires more than a…

      AI in Drug Discovery

      Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery

      Scientist in gloves places sample tubes into a rack beside a large laboratory analyzer.

      Beyond the Purity Percentage

      The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients

      The Engine of Cell Therapy Success: Why Analytical Development Determines Whether…

      EZfill cartridge manufacturing

      Stevanato Group and Syntegon Join Forces to Drive Innovation

  • Press Releases
    • Exterior view of a white, multi‑story office building with many windows and a green SYNTEGON sign, trees lining the front, and a surrounding metal fence.

      Syntegon opens new OSD Customer Center in Fellbach

      Galsana brand for rare metabolic diseases

      Galen and POA Pharma unveil Galsana, a new global brand for…

      Centrix Pharma Sussex KTP

      Centrix Pharma Solutions and University of Sussex partner to advance data-driven…

      pilot-scale tablet coater

      Syntegon Expands Sepion Series With New Pilot-Scale Tablet Coater

      DeepCyte Launches World's First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance

      DeepCyte Launches World’s First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma…

  • Events
  • Reports
  • BioPharma
  • Nutraceutical
  • More
    • Contact Us
    • Interviews
    • White Papers
    • Newsletter Archive
    • Target Audience
    • Magazine Issues
    • Testimonials
    Client Image

    Financial Times

    Visit Corporate Website

    Client Img

    Financial Times

    Email: aoife.grimes@ft.com
    Visit Corporate Website

    The Financial Times is one of the world’s leading news organisations, recognised internationally for its authority, integrity and accuracy.

    Events

    Contact Financial Times

    By submitting this form you agree to allow www.worldpharmatoday.com to contact you regarding your enquiry.
    See our Privacy Policy to learn more.

    Logo
    • Clinical Trials
    • Drug Research
    • IT & Data Management
    • Packaging & Labelling
    • Home
    • News
    • Articles
    • Press Releases
    • Interviews
    • White Papers
    • Industry Reports

    About us

    World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

    Facebook
    Instagram
    Linkedin
    Twitter
    Youtube

    SUBSCRIBE US

    • Newsletter Subscription
    • Content Submission Form
    • Subscribe for E-Magazine
    • Subscribe for Magazine – Printed Copy
    • Subscribe for Events

    System

    • Sitemap
    • RSS Feed
    • Privacy Policy

    RESOURCES

    • Target Audience
    • Advertise With Us
    • Submit Your Events
    • Media Pack
    • Contact Us

    ARCHIVE LINKS

    • Newsletter Archive
    • Print Issues
    • Search

    Subscribe

    Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

    Translate »
    MORE STORIES
    Biomarkers, Second Opinion, and Immunotherapy Planning for Stage 4 Colon Cancer With Booking Health

    Biomarkers, Second Opinion, and Immunotherapy Planning for Stage 4 Colon Cancer...

    Purity on Paper Isn’t Enough: How Procurement Teams Are Raising the...

    Newsletter Subscription